Zosano Pharma (ZSAN) Misses Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts ZSAN Hot Sheet
Join SI Premium – FREE
Zosano Pharma (NASDAQ: ZSAN) reported Q3 EPS of ($0.72), $0.11 worse than the analyst estimate of ($0.61).
For earnings history and earnings-related data on Zosano Pharma (ZSAN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
